Who are MOBILion Systems, Inc.'s investors?

MOBILion Systems, Inc.'s investors include Anzu Partners, iSelect Fund, Cultivation Capital.

How much funding has MOBILion Systems, Inc. raised?

MOBILion Systems, Inc. has disclosed $105.1M raised across 4 rounds.

Where is MOBILion Systems, Inc. headquartered?

MOBILion Systems, Inc. is headquartered in Exton, US.

MOBILion Systems, Inc.

Exton, US · Founded 2015 · Delaware corporation · 42 employees on LinkedIn · 3 known investors

Find your way into MOBILion Systems, Inc.

176 people in our graph share verified history with the MOBILion Systems, Inc. team — schools, employers, funds. One of them is your warm intro.

Jackson Heddyunlockedknows MELISSA SHERMAN · together at IP Group plc (overlapped)

×5knows the team · via DuPont

knows the team · via MOBILion Systems, Inc.

knows the team · via IP Group plc

×3knows the team · via University of Wisconsin-Eau Claire

knows the team · via The University of Akron

MOBILion Systems develops the MOBIE platform, a high-resolution ion mobility mass spectrometry (HRIM-MS) instrument that separates and identifies complex molecules in separation science. It serves pharmaceutical, biopharma, academic, and diagnostics labs across cell and gene therapy, therapeutic characterization, food and environmental testing, and biomarker research.

Biotech Deep Tech Hardware

Founders & leadership

MELISSA SHERMAN inChief Executive OfficerMelissa Sherman is an executive with 25 years of experience across life science tools, medical devices, materials science, and early-stage investing at companies including DuPont, W.L. Gore & Associates, Kensey Nash, DSM Biomedical, and IP Group. She is CEO of MOBILion Systems, an analytical instrumentation company developing high-resolution ion mobility mass spectrometry platforms.

Board

JASON SMITH inBoard of DirectorsPartner at Anzu Partners

MICHAEL ALBINBoard director

JUDIT LOSONCZIBoard director

HEINER DREISMANNBoard director

Investors · 3

Anzu PartnersBillerica

iSelect FundSt. Louis · $250K – $2M

Cultivation CapitalreportedSt. Louis · $100K – $3.5M

Reported raises · per SEC filings

Form D private placements

$105.1M disclosed across 4 rounds · 2019–2021

▶$60MraisedJul 2021 · 7 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

MELISSA SHERMANExecutive Officer, Director
TAD WEEMSDirector
JASON SMITHDirector
HEINER DREISSMANDirector
TODD SONEDirector
MICHAEL ALBINDirector
CRAIG CARRAExecutive Officer

Offering amount: $60M
Amount sold: $60M
Proceeds to insiders: $4M
First sale: Jun 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$35.1MraisedAug 2020 · 7 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

TODD SONEDirector
JASON SMITHDirector
HEINER DREISSMANDirector
MICHAEL ALBINDirector
TAD WEEMSDirector
MELISSA SHERMANExecutive Officer, Director

Offering amount: $35.1M
Amount sold: $35.1M
Minimum investment: $250K
Proceeds to insiders: $1.5M
First sale: Jul 2020
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6MraisedMay 2020 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Melissa ShermanExecutive Officer, Director
Heiner DreissmanDirector
Jason SmithDirector
Alan AubreyDirector
Tad WeemsDirector
Michael AlbinDirector

Offering amount: $6M
Amount sold: $6M
Minimum investment: $6M
Proceeds to insiders: $250K
First sale: May 2020
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$4MraisedApr 2019 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

MICHAEL ALBINDirector
JUDIT LOSONCZIDirector
HEINER DREISMANNDirector
MELISSA SHERMANExecutive Officer, Director
JASON SMITHDirector

Offering amount: $10M
Amount sold: $4M
Minimum investment: $3
First sale: Mar 2019
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Agilent13 shared keywordsAgilent manufactures laboratory instruments, software, reagents, and consumables for pharmaceutical, diagnostics, clinical research, and applied markets including chemicals, food, and environmental sectors. The company operates through three segments: Life Sciences and Diagnostics Markets (which includes contract manufacturing services for oligonucleotide therapeutics and pathology solutions), Agilent CrossLab (providing lab services and automation), and Applied Markets (offering analytical instruments and software).

Sciex10 shared keywordsSCIEX develops mass spectrometry and capillary electrophoresis instruments, along with software and integrated workflows, for the precision detection and quantitation of molecules. Its products serve research scientists and clinical laboratories, including in vitro diagnostic applications.

Companies competing with MOBILion Systems, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

MOBILion Closes $35M Series B Financing Roundprnewswire.com · Aug 2020

Frequently asked questions

What does MOBILion Systems, Inc. do?: MOBILion Systems develops the MOBIE platform, a high-resolution ion mobility mass spectrometry (HRIM-MS) instrument that separates and identifies complex molecules in separation science. It serves pharmaceutical, biopharma, academic, and diagnostics labs across cell and gene therapy, therapeutic characterization, food and environmental testing, and biomarker research.
Who are MOBILion Systems, Inc.'s investors?: MOBILion Systems, Inc.'s investors include Anzu Partners, iSelect Fund, Cultivation Capital.
How much funding has MOBILion Systems, Inc. raised?: MOBILion Systems, Inc. has disclosed $105.1M raised across 4 rounds.
Where is MOBILion Systems, Inc. headquartered?: MOBILion Systems, Inc. is headquartered in Exton, US.